How to Maintain a Competitive Edge in an Era of Increased M&A
by Emily Vernon, Innovation Analyst, RTI International Because of the imperative to innovate following the COVID-19 public health
It Starts Here
by Brian Johnson, President, MassMEDIC Massachusetts is the heart of healthtech, with more than 420 medical device companies
Addressing Health Disparities and Improving Access to Care in a Post-COVID World
by Ashley McEvoy, Executive Vice President, Worldwide Chairman, Medical Devices, Johnson & Johnson COVID-19 has solidified to the
Patient Engagement Moves Medtech to the Front of the Line
By Brian Chapman Brian is a principal at ZS and leads the medtech practice. He has worked with
Post-COVID innovation: How U.S. medtech can capitalize on this moment
by Jeff Mirviss, President, Peripheral Interventions at Boston Scientific Note: This blog post first appeared in the Star
Three Use Cases for Real-World Data & Artificial Intelligence for Devices and Diagnostics
By Joseph Zabinski, PhD, Senior Director of AI & Precision Medicine, OM1 As innovation in devices and diagnostics
Moving the Needle
Note: This post originally appeared on AdvaMed.org on Oct. 30, 2020. AdvaMed Advance® recently hosted more than 200
